A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Subscribe to our newsletter for the latest sci-tech news ...

The raise will support Rivermark’s pivotal trial, while allowing the medtech company to ready its FloStent system for ...

Butterfly Medical announced today that it completed its Series C funding round, bringing in $21 million to support its BPH ...

Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

ProUroCare Medical, Inc., of Minneapolis, Minn., has filed a de novo application with the FDA seeking marketing clearance for its prostate mechanical imaging (PMI) device (ProUroScan). This will allow ...

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) issued draft guidance Tuesday to support clinical testing of high-intensity ultrasound systems for ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

Clinical studies of Dr Allen’s US Patented Thermobalancing Therapy in men with benign prostatic hyperplasia or benign prostatic enlargement (BPE or BPH) have demonstrated the efficacy and safety of ...

(WDBJ) - September is National Prostate Cancer Awareness month. One in eight men will develop prostate cancer in their lifetimes, and 35,000 men will die this year from it. For many men, it’s a ...